Milan 2012 Programme Registration Exhibition Hotels Exhibitor Listing Satellite Meetings Visa Information
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Evaluation of a presbyopia LASIK treatment in hyperopic presbyopes: one year post-operative follow-up

Poster Details

First Author: M.Cesena MEXICO

Co Author(s):                  

Abstract Details


Prospective clinical study into the safety and efficacy of the treatment of presbyopic hyperopes with the Supracor excimer LASIK algorithm




In this single site, multi-surgeon, clinical study, 35 presbyopic hyperopes were treated with the Supracor presbyopic LASIK procedure. The non-dominant eye was treated with Supracor using the Technolas 217P excimer laser (Technolas Perfect Vision). Where needed, the fellow eye was treated with a standard LASIK procedure. Over a one year follow-up period, uncorrected near and distance visual acuity (UNVA, UDVA) and distance corrected near and best corrected distance visual acuity (DCNVA, BSCVA), safety, refraction and patient satisfaction were assessed.


Mean patient age was 50.1 years (range 45-60 years). Pre-operative mean manifest spherical equivalent (MRSE) and mean cylinder were 1.26D and 0.51D. At 6 months post-operatively, MRSE and cylinder were -0.73D and 0.38D, respectively. At 6 months post-op, 77% achieved monocular UNVA of 0.8 or better and 86% had binocular UNVA of 0.8. For binocular UDVA, 100% were 0.8 or better and 87% were 1.0. 100% patients had monocular BSCVA of 0.8 or better and 90% were 1.0. The patient questionnaire found a high level of patient satisfaction. Further one year post-op data will be presented.


Treatment of presbyopic hyperopic patients with the SUPRACOR LASIK procedure is safe and effective treatment, resulting in a high level of spectacle independence. FINANCIAL DISCLOSURE?: ... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous

loading Please wait while information is loading.